Two collagen type IX gene polymorphisms that introduce a tryptophan residue into the protein's triple-helical domain have been linked to an increased risk of lumbar disc disease. To determine whether a particular subset of symptomatic lumbar disease is specifically associated with these polymorphisms, we performed a prospective case-control study of 107 patients who underwent surgery of the lumbar spine. Patients were assigned to one of five clinical categories (fracture, disc degeneration, disc herniation, spinal stenosis without spondylolisthesis and spinal stenosis with spondylolisthesis) based on history, imaging results, and findings during surgery. Of the 11 tryptophan-positive patients, eight had spinal stenosis with spondylolisthesis and three had disc herniation. The presence of the tryptophan allele was significantly associated with African-American or Asian designation for race (odds ratio 4.61, 95% CI 0.63 to 25.35) and with the diagnosis of spinal stenosis with spondylolisthesis (odds ratio 6.81, 95% CI 1.47 to 41.95).
Two collagen type IX gene polymorphisms that introduce a tryptophan residue into the protein's triple-helical domain have been linked to an increased risk of lumbar disc disease. To determine whether a particular subset of symptomatic lumbar disease is specifically associated with these polymorphisms, we performed a prospective case-control study of 107 patients who underwent surgery of the lumbar spine. Patients were assigned to one of five clinical categories (fracture, disc degeneration, disc herniation, spinal stenosis without spondylolisthesis and spinal stenosis with spondylolisthesis) based on history, imaging results, and findings during surgery. Of the 11 tryptophan-positive patients, eight had spinal stenosis with spondylolisthesis and three had disc herniation. The presence of the tryptophan allele was significantly associated with African-American or Asian designation for race (odds ratio 4.61, 95% CI 0.63 to 25.35) and with the diagnosis of spinal stenosis with spondylolisthesis (odds ratio 6.81, 95% CI 1.47 to 41.95).
Our findings indicate that tryptophan polymorphisms predispose carriers to the development of symptomatic spinal stenosis associated with spondylolisthesis which requires surgery.
Disorders of the lumbar spine are the most common musculoskeletal complaints, with a lifetime incidence of low back pain in the range 49% to 70%. 1 Occupational risk factors such as lifting heavy loads and driving a motor vehicle are well known, and recent studies reveal significant genetic risks. 2 Type IX collagen, a heterotrimer of genetically distinct α1(IX), α2(IX) and α3(IX) chains, is a structural component of the matrix of hyaline cartilage that functions as an interfacial protein in covalent cross-linkage to the surface of type II collagen fibrils. 3 Type IX collagen is important for the normal development and maintenance of cartilage. Mutations in type IX collagen genes cause chondrodysplasias in humans (multiple epiphyseal dysplasia with early development of osteoarthritis) and progressive degeneration of articular cartilage and intervertebral discs in mice. 4 Analysis of the type IX collagen genes in a Finnish population linked the polymorphic variants that encode tryptophan at position 326 of the α2(IX) chain (Trp2) or at position 103 of the α3(IX) chain (Trp3) to an increased risk of lumbar disc disease and chronic sciatica. 5, 6 Since lumbar degeneration is not one entity but consists of several related clinical phenotypes, we performed a case-control study of 108 patients who underwent fusion of the lumbar spine to determine whether a certain subset of degeneration of the lumbar spine is specifically associated with the tryptophan polymorphisms.
Patients and Methods
Study design. The goal of the study was to determine whether genetic changes in the structure of collagen predispose individuals to any particular subtype of degeneration of the lumbar spine. We designed a prospective casecontrol study to investigate the association between the presence of a genetic risk factor (a tryptophan allele polymorphism for collagen type IX) and clinical subtypes of degenerative disease of the lumbar spine requiring surgical treatment, graded according to severity. Patients. The Institutional Review Board at the University of Washington approved this study. The participating surgeons screened all patients scheduled for surgery of the lumbar spine. Those patients in which the planned procedure involved excision of one or more intervertebral disc were invited to participate and given a description of the study for informed consent. We anticipated enrolling 120 patients over a one-year interval (June 2001 to May 2002). Overall, 108 patients elected to be included in the study, however, one was excluded from the analysis. There were 50 men and 57 women, with a mean age of 48.3 years (16 to 87). The racial profile was seven African American, three Asian, 94 Caucasian, and three others (one Middle Eastern, one Native American, and one Pacific Islander).
Surgeons (SKM, CB, CIS, JRC) collected disc tissue and a blood sample at the time of surgery. The disc and blood specimens were labelled with a randomly-generated study code. The team for laboratory analysis had no access to information regarding the patient, surgeon, disease, procedure, date, or any other clinical details. Clinical categorisation. The broad category of degenerative disc disease may encompass pathophysiologically distinct entities. As a validated classification of degenerative disc disease does not exist, we chose to group lumbar degenerative disorders into surgically meaningful clinical categories. Four surgeons (SKM, CB, CIS, JRC) reached a consensus for ranking lumbar degenerative disease into five clinical categories reflecting progressively severe degenerative changes; 7,8 1) no lumbar degeneration (to include patients with a lumbar vertebral fracture treated by fusion); 2) lumbar degeneration treated by fusion; 3) lumbar disc herniation treated by open micro-discectomy; 4) lumbar degenerative spinal stenosis without spondylolisthesis treated by decompression and fusion; and 5) degenerative stenosis with spondylolisthesis treated by decompression and fusion.
We did not sub-classify spinal stenosis further as this would have reduced the sample size for each sub-group, making interpretation of results difficult. Each surgeon classified his respective patients into one of these five categories. One of the investigators (SM) reviewed the medical records and imaging studies of all patients and independently assigned each one a specific category. One patient enrolled in the 'fracture' category was excluded from the analysis due to a history of chronic back pain preceding the fracture and the radiographs showed advanced degenerative changes at the time of fracture.
The patients' race was identified by the response marked by the patient on the American Academy of Orthopaedic Surgeons MODEMS questionnaire. 9 Where the response to the item for race was missing (24 patients), we identified race through the medical records. The medical records were also reviewed for the pattern and distribution of symptoms, the presence of a neurological deficit, and the type of surgical procedure performed. (Table II) . All 11 Trp(+) patients were heterozygotic for one Trp codon; four were Trp2+ and seven were Trp3+. The genotype was independent of age, race, gender, and spinal level of most severe disease. The presence of the Trp-allele, however, was not equally distributed across the diagnostic classification categories (p value = 0.034 for chi-square test with more than two categories, alpha = 0.05 (significance for p value)). In particular, the Trp(+) allele was found in the patients with spinal stenosis with spondylolisthesis: eight of 35 (23%) patients with spondylolisthesis were Trp(+) compared with three of 34 (9%) for disc herniation, and none in the other three diagnostic groups (fracture, disc degeneration, and spinal stenosis without spondylolisthesis). All 11 patients with a Trp(+) allele had nerve root symptoms, and four also had back pain. Unadjusted odds ratio for the association between Trp(+) allele and race, gender, age, and diagnosis are reported in Table III . Trp(+) allele is associated with racial designation of African-American or Asian (odds ratio 4.61 with Caucasian as the reference group, p value = 0.357) and a diagnosis of spondylolisthesis (odds ratio 6.81, p value = 0.0028). Anteroposterior (a) and lateral (b) radiographs of the lumbar spine of a Trp3+ patient (case 7 in Table II) showing extensive disc degeneration and osteophyte formation throughout the lumbar spine and grade 1 degenerative spondylolisthesis at L4/5.
MRI images from a Trp3+ patient (case 8 in Table II ) with spondylolisthesis. Sagittal T1 (a) and T2 (b) weighted MRI images of a 50-year-old woman showing grade 2 isthmic spondylolisthesis of L5/S1 with 30% anterior translation of L5 on S1. The patient had a five-year history of progressive back pain prior to the surgery. There was also a bilateral pars defect at L5. Radiographs of a Trp(+) patient with degenerative stenosis and spondylolisthesis (case 7 in Table II ) are shown in Figure 1 . MRI of an illustrative Trp(+) patient with degeneration and isthmic spondylolisthesis (case 8 in Table 2 ) are shown in Figure 2 . Spondylolisthesis. We assessed the contribution of four risk factors on the diagnostic category of 'spinal stenosis with spondylolisthesis'. The unadjusted and adjusted odds ratio are listed in Tables IV and V, respectively. Three risk factors (Trp(+) allele, female gender, and age ≥50 years) are independently associated with the diagnosis of spondylolisthesis. Although race designation of African-American or Asian is associated with Trp(+) allele, this race category is not associated with the diagnosis of spondylolisthesis.
Discussion
We found an association between changes of genotype in collagen type IX and the African-American or Asian race and a diagnosis of spondylolisthesis. Our results indicate that the tryptophan polymorphisms are linked to the development of symptomatic spondylolisthesis requiring surgery. All the patients with spondylolisthesis in this study had decompression and fusion surgery to treat symptoms of back pain and nerve root compression, not primarily to treat loss of sagittal balance or progression of slipping, as is common in children. The combination of degenerative changes causing nerve root symptoms and spondylolisthesis indicates that tryptophan polymorphisms may be associated with more severe degeneration resulting in stenosis of the spinal canal or neuroforamina 11 and slipping of the adjacent vertebrae. Another possible explanation for the association of tryptophan polymorphisms and symptomatic spondylolisthesis is chronic inflammatory irritation of the nerve roots at the site of the lumbar stenosis, 12 and degradation products of tryptophan-containing type IX collagen may cause an inflammatory response and local nerve root irritation. Oxidised tryptophan residues and other oxidation products in low-density lipoproteins are believed to contribute to the chronic inflammation linked to the pathogenesis of atherosclerosis. 13 The nucleus pulposus is gel-like and has a similar collagen phenotype to that of hyaline cartilage. Although the collagen phenotype of hyaline cartilage is complex, the developing fibrillar network is a cross-linked co-polymer of collagens II, IX and XI.
14 The human α1(IX) gene gives rise to two mRNA transcripts, a long and a short form. 15 Hyaline cartilage such as articular cartilage expresses the long form of the α1(IX) chain, which has a globular N-terminal domain, NC4. The matrix of bovine nucleus pulposus also contains IX collagen, but only the short form of α1(IX) chain lacking the NC4 domain is present. 16 Despite extensive cross-linking to type II collagen and to other molecules of type IX collagen in a similar pattern to that in cartilage, the function of type IX collagen in the nucleus pulposus may differ from than in articular cartilage. This potential structural difference may in part explain the association of the tryptophan polymorphisms with clinical conditions involving discs but not synovial joints. 5, 6 Type IX collagen consists of three triple-helical segments, COL1, COL2 and COL3 and four non-helical domains, NC1-NC4. Trp2 is in the middle of α2(IX)COL2 and Trp3 is in the middle of α3(IX)COL3. Since Trp2 is within a few residues of the site of cross-linking between the α3(IX) chain and the type II collagen C-telopeptide, 17 ,18 a local effect on this interaction is one possible consequence. Similarly, Trp3 may affect interactions between COL3(IX), which sticks out from the fibril, and interfibrillar matrix molecules.
However, analysis of samples of embryonic and foetal human cartilage has shown that both Trp2 and Trp3 allelic products are normally incorporated into the cross-linked fibrillar network. 10 Therefore, if this proves to be also true for adult intervertebral disc tissue, any pathological consequences are likely to be long-term rather than from overt change of matrix.
Lumbar degenerative disease is a broad group of conditions. Our study suggests that better clinical distinction and stratification of subtypes of lumbar degenerative disease may be helpful in identifying biological mechanisms underlying specific conditions within this broad classification. We have no control database on the frequency of the Trp2 and Trp3 alleles in the population from which the patients were drawn, and therefore, we cannot assess whether the Trp(+) allele is associated with an increased risk of lumbar disc disease in general. It is possible that the risk of degenerative changes leading to spinal stenosis and spondylolisthesis is much higher in Trp(+) than in Trp(-) individuals, or that Trp(+) patients are more likely to develop symptoms which require surgical treatment. One strength of our study is that we separated clinically distinct categories of lumbar degenerative disease. On the other hand, this is also a weakness as the diagnosis grouping is based on the opinions of the treating surgeon and one surgeon reviewer, and not on a validated, pre-established classification of disease. A validated classification of lumbar degenerative disorders which accounts for severity would enhance studies of their aetiology.
In conclusion, our study suggests a relationship between relatively common tryptophan polymorphisms in collagen type IX gene and degenerative spondylolisthesis. Biochemical studies on disc tissue obtained from the subjects with the tryptophan allele may provide clues as to the molecular basis of the link.
